ATE309007T1 - Transplantate für die wiederherstellung von osteochondralen schäden - Google Patents

Transplantate für die wiederherstellung von osteochondralen schäden

Info

Publication number
ATE309007T1
ATE309007T1 AT02726105T AT02726105T ATE309007T1 AT E309007 T1 ATE309007 T1 AT E309007T1 AT 02726105 T AT02726105 T AT 02726105T AT 02726105 T AT02726105 T AT 02726105T AT E309007 T1 ATE309007 T1 AT E309007T1
Authority
AT
Austria
Prior art keywords
transplants
restoration
dimensional matrix
osteochondral damage
constituted
Prior art date
Application number
AT02726105T
Other languages
English (en)
Inventor
Alessandra Pavesio
Lanfranco Callegaro
Original Assignee
Fidia Advanced Biopolymers Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Advanced Biopolymers Srl filed Critical Fidia Advanced Biopolymers Srl
Application granted granted Critical
Publication of ATE309007T1 publication Critical patent/ATE309007T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3817—Cartilage-forming cells, e.g. pre-chondrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/12—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843—Connective tissue
    • A61L27/3852—Cartilage, e.g. meniscus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/42—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix
    • A61L27/425—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix of phosphorus containing material, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/46—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Composite Materials (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Cultivation Of Seaweed (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Dental Preparations (AREA)
  • Earth Drilling (AREA)
  • Excavating Of Shafts Or Tunnels (AREA)
  • Cosmetics (AREA)
AT02726105T 2001-02-09 2002-02-06 Transplantate für die wiederherstellung von osteochondralen schäden ATE309007T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001PD000032A ITPD20010032A1 (it) 2001-02-09 2001-02-09 Innesti ingegnerizzati per la riparazione di difetti osteocondrali
PCT/EP2002/001224 WO2002070030A1 (en) 2001-02-09 2002-02-06 Grafts for the repair of osteochondral defects

Publications (1)

Publication Number Publication Date
ATE309007T1 true ATE309007T1 (de) 2005-11-15

Family

ID=11452207

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02726105T ATE309007T1 (de) 2001-02-09 2002-02-06 Transplantate für die wiederherstellung von osteochondralen schäden

Country Status (11)

Country Link
US (1) US7968111B2 (de)
EP (1) EP1357953B1 (de)
JP (1) JP2004524904A (de)
AT (1) ATE309007T1 (de)
AU (1) AU2002256617B8 (de)
CA (1) CA2437440C (de)
DE (1) DE60207198T2 (de)
DK (1) DK1357953T3 (de)
ES (1) ES2250642T3 (de)
IT (1) ITPD20010032A1 (de)
WO (1) WO2002070030A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10260958A1 (de) * 2002-12-20 2004-07-08 Sustech Gmbh & Co. Kg Kompositmaterialien aus Calciumverbindungen und Glucuronsäure- und/oder Iduronsäurehaltigen Polysacchariden
AU2004216551B2 (en) 2003-02-26 2008-09-18 Zimmer Orthobiologics, Inc. Preparation for repairing cartilage tissue, especially articular cartilage defects
US20050074877A1 (en) * 2003-07-28 2005-04-07 Mao Jeremy Jian Biological engineering of articular structures containing both cartilage and bone
ITPD20030286A1 (it) 2003-11-27 2005-05-28 Fidia Advanced Biopolymers Srl Strutture composite multistrato contenenti acido ialuronico
US7666230B2 (en) 2003-12-08 2010-02-23 Depuy Products, Inc. Implant device for cartilage regeneration in load bearing articulation regions
ITPD20040053A1 (it) * 2004-02-27 2004-05-27 Fidia Advanced Biopolymers Srl Biomateriali costituiti da derivati dell'acido ialuronico come nuova terapia di cura per la protezione e la la riparazione della cartilagine articolare danneggiata per osteoartrosi
EP1791496B1 (de) 2004-08-31 2019-07-31 C.R. Bard, Inc. Selbstschliessendes ptfe-implantat mit knickbeständigkeit
CA2611119A1 (en) * 2005-06-08 2006-12-14 C.R. Bard Inc. Grafts and stents having inorganic bio-compatible calcium salt
US8066758B2 (en) 2005-06-17 2011-11-29 C. R. Bard, Inc. Vascular graft with kink resistance after clamping
DE102005030614B4 (de) * 2005-06-30 2014-05-08 Biotissue Ag Zellfreies Transplantat, dessen Verwendung, Verfahren zu dessen Herstellung, dabei hergestellte Matrix mit Gel und Verfahren zur Herstellung dieser Matrix mit Gel
WO2007007062A2 (en) * 2005-07-08 2007-01-18 Depuy International Limited Cartilage repair implant
EP1764117A1 (de) 2005-09-20 2007-03-21 Zimmer GmbH Implantat zur Wiederherstellung von Knorpeldefekten und Verfahren zu seiner Herstellung
CA2626598A1 (en) 2005-11-09 2007-05-18 C.R. Bard Inc. Grafts and stent grafts having a radiopaque marker
CN100398496C (zh) * 2005-12-29 2008-07-02 武汉理工大学 层状多孔磷酸钙生物陶瓷的制备方法及其应用
JP5173199B2 (ja) * 2006-01-16 2013-03-27 株式会社アイ・ティー・オー 創傷治癒用高分子組成物
JP5538493B2 (ja) * 2006-01-16 2014-07-02 株式会社アイ・ティー・オー 生体内組織用創傷治癒用フィルム及び生体内接着用フィルム
DE102006047346A1 (de) * 2006-10-06 2008-04-10 Transtissue Technologies Gmbh Matrix-Gel-Transplantat ohne Zellen
US9198749B2 (en) 2006-10-12 2015-12-01 C. R. Bard, Inc. Vascular grafts with multiple channels and methods for making
WO2008049281A1 (en) * 2006-10-27 2008-05-02 Beijing Institute Of Transfusion Medicine Construction method of hepatic tissue engineering construct and the hepatic tissue engineering construct
CN103169731A (zh) 2007-08-06 2013-06-26 成血管细胞系统公司 用于体内生成、修复和/或维护结缔组织的方法
AU2013203054B2 (en) * 2007-08-06 2017-05-18 Mesoblast, Inc. Methods of generating, repairing and/or maintaining connective tissue in vivo
US8524494B2 (en) 2008-01-30 2013-09-03 Histogen, Inc. Low oxygen tension and BFGF generates a multipotent stem cell from a fibroblast in vitro
JP5647007B2 (ja) * 2008-01-30 2014-12-24 ヒストジェン インコーポレイテッド 細胞外マトリックス組成物
US8535913B2 (en) * 2008-01-30 2013-09-17 Histogen, Inc. Soluble composition for promoting hair growth produced by hypoxic culture of fibroblasts cells
US8530415B2 (en) * 2008-01-30 2013-09-10 Histogen, Inc. Repair and/or regeneration of cells with a composition produced by culturing fibroblast cells under hypoxic conditions
KR20170104643A (ko) 2008-06-25 2017-09-15 메소블라스트, 아이엔씨. 추간판의 치료 및/또는 재구성
AU2010271212B2 (en) * 2009-07-10 2015-07-16 Histogen, Inc. Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions
WO2012051420A2 (en) 2010-10-13 2012-04-19 Cibor, Inc. Synthetic bone grafts constructed from carbon foam materials
WO2012099852A1 (en) 2011-01-17 2012-07-26 Cibor, Inc. Reinforced carbon fiber/carbon foam intervertebral spine fusion device
KR101306748B1 (ko) * 2012-03-29 2013-09-10 주식회사 바이오알파 성장인자 전달속도 조절이 가능한 히알루론산-인산칼슘 복합체 및 그 제조방법
WO2014041516A1 (en) 2012-09-14 2014-03-20 Ecole Polytechnique Federale De Lausanne (Epfl) Biocompatible multi-layered structure comprising foam layers and a functional interface
ES2751398T3 (es) 2013-01-15 2020-03-31 Tepha Inc Implantes para regeneración de tejido blando y tejido duro
JPWO2018097198A1 (ja) * 2016-11-28 2019-10-17 株式会社バイオ未来工房 間葉系幹細胞の分離方法及びリン酸カルシウム類を含有する不織布の使用
CN111787886A (zh) 2018-01-02 2020-10-16 卡尔蒂希尔(2009)公司 用于促进细胞和组织生长的优化固体基质的植入工具和方案
CN112552035A (zh) * 2020-12-11 2021-03-26 湖北联结生物材料有限公司 一种可诱导生物活性3d打印陶瓷及其制备方法
CN115317672B (zh) * 2022-08-27 2023-11-14 四川大学 仿生骨软骨一体化修复植入体及其制备方法与应用
EP4732856A1 (de) * 2023-06-21 2026-04-29 Kagoshima University Komplex zur knochenregeneration oder -verstärkung und verfahren zur herstellung davon
WO2026090254A1 (en) * 2024-10-22 2026-04-30 The Regents Of The University Of Colorado, A Body Corporate Permeable barrier to enhance regeneration at tissue interfaces and therapeutic methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9101853D0 (sv) * 1991-06-17 1991-06-17 Jonas Wadstroem Improved tissue ashesive
IT1259090B (it) * 1992-04-17 1996-03-11 Fidia Spa Biomaterialli per protesi d'osso
IT1263316B (it) * 1993-02-12 1996-08-05 Fidia Advanced Biopolymers Srl Tessuto non tessuto multistrato in cui uno degli strati e' costituito essenzialmente da esteri dell'acido ialuronico
WO1997045532A1 (en) * 1996-05-28 1997-12-04 Brown University Research Foundation Hyaluronan based biodegradable scaffolds for tissue repair
DE19803673A1 (de) * 1998-01-30 1999-08-05 Norbert M Dr Meenen Biohybrider Gelenkflächenersatz
US6872819B1 (en) * 1998-05-27 2005-03-29 Fidia Advanced Biopolymers S.R.L. Biomaterials containing hyaluronic acid derivatives in the form of three-dimensional structures free from cellular components or products thereof for the in vivo regeneration of tissue cells
ITPD980149A1 (it) * 1998-06-17 1999-12-17 Fidia Advanced Biopolymers Srl Protesi tridimensionali comprendenti derivati dell'acido ialuronico per riparare o ricostruire i tessuti danneggiati e processo per la
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
IT1302534B1 (it) * 1998-12-21 2000-09-05 Fidia Advanced Biopolymers Srl Composizioni iniettabili, biocompatibili e biodegradabili comprendentialmeno un derivato dell'acido ialuronico, cellule condrogeniche, per
US6656489B1 (en) * 1999-02-10 2003-12-02 Isotis N.V. Scaffold for tissue engineering cartilage having outer surface layers of copolymer and ceramic material
IT1306644B1 (it) 1999-04-08 2001-10-02 Fidia Advanced Biopolymers Srl Strutture tridimensionali comprendenti derivati dell'acido ialuronicoottenibili mediante la tecnica antisolvente supercritico.

Also Published As

Publication number Publication date
US20040076656A1 (en) 2004-04-22
DE60207198T2 (de) 2006-06-01
AU2002256617B2 (en) 2007-02-08
CA2437440C (en) 2012-04-03
WO2002070030A8 (en) 2002-12-05
AU2002256617B8 (en) 2007-02-15
ITPD20010032A1 (it) 2002-08-09
CA2437440A1 (en) 2002-09-12
EP1357953A1 (de) 2003-11-05
EP1357953B1 (de) 2005-11-09
DK1357953T3 (da) 2006-01-16
US7968111B2 (en) 2011-06-28
ES2250642T3 (es) 2006-04-16
WO2002070030A1 (en) 2002-09-12
JP2004524904A (ja) 2004-08-19
DE60207198D1 (de) 2005-12-15

Similar Documents

Publication Publication Date Title
DE60207198D1 (de) Transplantate für die wiederherstellung von osteochondralen schäden
ATE302616T1 (de) Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
IL153011A0 (en) Sustained release pharmaceutical compositions for parenteral administration of hydrophilic compounds
IL143706A0 (en) Polyol/oil suspensions for the sustained release of proteins
AU2845599A (en) Pharmaceutical compositions and their use
ZA200307161B (en) Medical aerosol formulations
BR0112962B1 (pt) Composições farmacêuticas compreendendo ácido hialurônico, ácido glicirretínico e polivinilpirrolidona, e uso desses compostos na preparação de medicamentos
IL155806A0 (en) Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
ATE513541T1 (de) Pharmazeutische zusammensetzungen zur oralen verabreichung von calcitonin
DE60018600D1 (de) Bioaktiver abbaubarer verbundstoff für "tissue engineering"
ID28510A (id) Formulasi oral yang baru untuk agonis atau antagonis 5-ht4
ATE464878T1 (de) Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl
MXPA04001252A (es) Nuevos heterociclos benzo-fusionados como antagonistas de endotelina.
ES2167939T3 (es) Nuevas poliaminas, su preparacion y usos.
UY27373A1 (es) Formulaciones de interferón beta-humano
HRP20020071B1 (hr) Farmaceutske kompozicije i pripravljanje istih
YU87501A (sh) Farmaceutski kompleksi
PL361732A1 (en) Use of a biological material containing three-dimensional scaffolds of hyaluronic acid derivatives for the preparation of implants in arthroscopy and kit for instruments for implanting said biological material by arthroscopy
MXPA04005033A (es) Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes.
SE9902742D0 (sv) New pharmaceutical formultion
AP2003002897A0 (en) Processes and intermediates for preparing benzyl epoxides
DE60000877D1 (de) Material für knochentransplantate aus calciumphosphat-keramik und knochengewebe
AP2001002320A0 (en) (7-(3-Carboxyphenyl)-4-Chloroisoquinolin-1-yl)Guanide.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1357953

Country of ref document: EP